Evidence suggests that exercise reduces blood pressure, and some of the mechanisms by which this occurs can include a reduction in salt sensitivity and effects on vascular structure, according to Danielle Kirkman, PhD, assistant professor at Virginia Commonwealth University.
Evidence suggests that exercise reduces blood pressure, and some of the mechanisms by which this occurs can include a reduction in salt sensitivity and effects on vascular structure, according to Danielle Kirkman, PhD, assistant professor at Virginia Commonwealth University.
Transcript
How does exercise affect hypertension, and what are the biological mechanisms?
There’s a wealth of research and a lot of evidence out there to suggest that exercise, particularly aerobic exercise, reduces blood pressure. There are several mechanisms by which this can occur; the biological mechanisms probably relate to a reduction in salt sensitivity, so that’s how much our blood pressure raises after we eat a high-sodium meal. Some data has shown that after an exercise intervention of about 6 months, our blood pressure raises less after a high-sodium meal, so that’s certainly one factor.
Other factors may be a reduction in the activation of the sympathetic nervous system, so this could certainly lead to less vasoconstriction and a blood pressure­­­—lowering effect. In addition to that, we know that exercise certainly has beneficial effects on the vascular structure and function, so this could certainly contribute to reducing hypertension. And then finally, we know that exercise is a potent anti-inflammatory and antioxidant, so by reducing inflammation and reducing oxidative stress, this could slowly lead to a reduction in blood pressure.
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
EMBARK Data Show Continued Improvements With DMD Gene Therapy
March 19th 2025Data from the EMBARK trial of delandistrogene moxeparvovec in patients with Duchenne muscular dystrophy (DMD) show that benefits in functional outcomes, gene expression, and muscle imaging persist 2 years after receiving the gene therapy.
Read More
How Access to SMA Treatment Varies Globally and by Insurance Type
March 18th 2025Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic advances in treating spinal muscular atrophy (SMA) are not uniformly making it into the hands of patients who could benefit.
Read More